Navigation Links
Trinitas Comprehensive Cancer Center Now Offering Cancer Patients Faster, Ultra-Precise Radiation Using New RapidArc Technology
Date:1/13/2009

the Trinitas Comprehensive Cancer Center; the Trinitas School of Nursing; the Center for Wound Healing & Hyperbaric Medicine; the Sleep Disorders Center; cardiology services, maternal/child health services; diabetes management; women's services, renal care; behavioral health services, and senior services.

About Trinitas Comprehensive Cancer Center

Trinitas Comprehensive Cancer Center (TCCC) is located in a new 28,000-square-foot, five-story building on the campus of Trinitas Hospital. The Center offers the most advanced technology available to cancer patients. Board-certified physicians, nurses and allied health professionals are passionate in their fight against cancer and their mission to provide excellent patient care. Trinitas Comprehensive Cancer Center is an affiliate of Aptium Oncology, a Los Angeles-based leader in building, developing and managing comprehensive outpatient cancer centers.

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,900 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. For more information, visit http://www.varian.com/.


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C
2. Nikon Instruments A1 Confocal Laser Microscope Series With NIS-Elements C Software Delivers Fully Integrated Comprehensive Confocal Imaging Capabilities
3. New Online Tutorial for the Comprehensive Microbial Resource (CMR)
4. Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions
5. Newly Integrated Software Suite From ZS Associates Offers Comprehensive Set of Sales Performance Management Software Solutions
6. Comprehensive Jatropha Standards Mandatory in Optimum Long-term Biofuel Efficacy
7. Satyam Forms Partnership with Sciformix to Provide Comprehensive Drug Safety Management
8. Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters
9. Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China
10. ACORN Expands Oncology Information Portfolio With Comprehensive Data Warehouse
11. CellCyte Genetics Corporation Announces Launch of Comprehensive Web site Powered by PRNewswire Investor Room Backend Technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., , NEW YORK, Dec. 2 /PRNewswire-USNewswi...entists, policy makers, and funders today convened...ative funding strategies at the inaugural Partner...Washington-based center of the Milken Institute, c...-sector collaborations needed to turn a scientific...
(Date:12/2/2009)..., , LELYSTAD, The Netherlands, Decemb...rlands based biotechnology company focusing on pro...mune therapeutics today announced that it,has appo...fficer. , Dr. Mol will be responsible for...ll management and strategic direction of the compa...
(Date:12/2/2009)..., , NANJING, China, Dec. 2 /PRNewsw...e" or the "Company") (NYSE: SCR ), a leading pha...t, manufacturing, and marketing of branded,generic...nnounced that 105 of,its drugs have been included ..."), which was issued by China,s Ministry of Human ...
(Date:12/1/2009)... Dr. Kerry Solomon announ... and has launched his redesigned website at www.D... Consulting Group. Dr. Solomon is a proven LASIK,... been professionally recognized for his substantia...gery. He is a member of Trusted LASIK Surgeons, w...
Breaking Biology Technology:Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Dutch Biotech Company Pepscan Appoints New CEO 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
...USALEM and NEEDHAM, Massachusetts, December 10 /PR...wiss Exchange: ORIDN) today announced that,three s...be presented at the,upcoming AARC (American Associ...alifornia. These studies confirm the clinical bene...dion Microstream(R) capnography technology,and cle...
...SANNE, Switzerland, December 10 Diagnoplex, a,dev...nced the closing of a,Series A financing raising C...y Novartis Venture Fund and NeoMed, with Initiativ...rtis Venture Fund was also a seed investor in the,...stors and BMP Associés,acted as counsel to the co...
...MOUTH, Minn., Dec. 9 ev3 Inc. (Nasdaq: EVVV ),a...ay that it has received,510(k) clearance from the ...t its,EverCross 0.035" and NanoCross 0.014" periph...o begin full commercialization of the EverCross an...in January 2009. , Robert Palmisano, ev3,s presi...
Other Biology Technology:Oridion Announces Significant Medical Research to be Presented at AARC Congress 2Oridion Announces Significant Medical Research to be Presented at AARC Congress 3Diagnoplex Closes CHF10 Million ($8.3 Million) Series A Financing 2Diagnoplex Closes CHF10 Million ($8.3 Million) Series A Financing 3ev3 Inc. Receives FDA Clearance to Market EverCross and NanoCross Peripheral Angioplasty Balloons 2ev3 Inc. Receives FDA Clearance to Market EverCross and NanoCross Peripheral Angioplasty Balloons 3
(Date:12/2/2009)...tudy results strengthen the evidence that people w...e an increased risk for developing colorectal canc..., "This provides one more reason not to smoke, o... Michael J. Thun, M.D., M.S., vice president emeri... American Cancer Society. "Colorectal cancer shoul...
(Date:12/2/2009)...ce of a cancer-free status did not prompt people p...y (CT) lung-cancer screening program to pick up th... published in Cancer Epidemiology, Biomarkers & P...for Cancer Research. The December issue contains a...ld negate widespread concern in the lung screening...
(Date:12/2/2009)...iversity Medical Center researchers have figured o...ioma may be better able to resist radiation therap...g pathway in these cancer stem cells, they were ab...n a laboratory experiment. , The work builds of...ells resist the effects of radiation much better t...
Breaking Biology News(10 mins):Cigarette smoking increases colorectal cancer risk 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Discovery makes brain tumor cells more responsive to radiation 2Certain Arthritis Crohns Drugs May Raise Kids Cancer Risk 3A FDA 53660 1Certain Arthritis Crohns Drugs May Raise Kids Cancer Risk 3A FDA 53660 2Certain Arthritis Crohns Drugs May Raise Kids Cancer Risk 3A FDA 53660 3Silenced genes as a warning sign of blood cancer 53655 1Silenced genes as a warning sign of blood cancer 53655 2Nanotechnology Transforms Pain Relief 53652 1Nanotechnology Transforms Pain Relief 53652 2Nanotechnology Transforms Pain Relief 53652 3Nanotechnology Transforms Pain Relief 53652 4
...om The Wistar Institute in Philadelphia and The Vi...mechanism involved in normal repression of the p53...le for the control of cancer in humans. , The new... intriguing approaches to diagnosing or intervenin...port on the team,s findings will be published onli...
...ervational study by researchers at the University ...n between 65 and 80 years of age who received trea...ived significantly longer than men who did not rec... December 13th issue of the Journal of the America...revention education and the resulting wide-spread ...
...mazing protein-making parts out of cells and putti...eins for a wide variety of medical uses. At the an...) Sept. 13 in San Francisco, Stanford engineering ...ch "cell-free" protein synthesis, including produc...n act as delivery trucks for a new class of potent...
Other Biology News:Novel regulatory mechanism identified for key tumor suppressor p53 2Novel regulatory mechanism identified for key tumor suppressor p53 3Older men treated for early prostate cancer live longer than those who are not 2Engineer ramps up protein production, develops versatile viral spheres 2Engineer ramps up protein production, develops versatile viral spheres 3
Chicken Anti-Plants Thaumatin 2 Polyclonal Antibody, Unconjugated from Abcam
Proteinase K Buffer from BD Biosciences Pharmingen
Rabbit Anti-VEGF Receptor 2, phospho (Tyr1214) Polyclonal Antibody, Unconjugated from Abcam
Glutathione Agarose Beads from BD Biosciences Pharmingen
Biology Products: